AllianceBernstein’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $108M | Buy |
220,634
+14,091
| +7% | +$7.02M | 0.03% | 370 |
|
|
2025
Q4 | $101M | Buy |
206,543
+26,141
| +14% | +$12.2M | 0.03% | 390 |
|
|
2025
Q3 | $75.6M | Sell |
180,402
-115,669
| -39% | -$38.9M | 0.02% | 508 |
|
|
2025
Q2 | $85.1M | Sell |
296,071
-158,912
| -35% | -$47.5M | 0.03% | 447 |
|
|
2025
Q1 | $140M | Sell |
454,983
-254,060
| -36% | -$87.1M | 0.05% | 274 |
|
|
2024
Q4 | $250M | Buy |
709,043
+157,363
| +29% | +$57.8M | 0.08% | 182 |
|
|
2024
Q3 | $198M | Buy |
551,680
+12,063
| +2% | +$4.07M | 0.07% | 222 |
|
|
2024
Q2 | $172M | Buy |
539,617
+66,332
| +14% | +$17.6M | 0.06% | 238 |
|
|
2024
Q1 | $109M | Buy |
473,285
+369,130
| +354% | +$83.3M | 0.04% | 383 |
|
|
2023
Q4 | $22.9M | Buy |
104,155
+12,370
| +13% | +$2.85M | 0.01% | 829 |
|
|
2023
Q3 | $20.7M | Buy |
91,785
+11,068
| +14% | +$2.55M | 0.01% | 830 |
|
|
2023
Q2 | $17.8M | Buy |
80,717
+10,544
| +15% | +$2.34M | 0.01% | 897 |
|
|
2023
Q1 | $15.7M | Buy |
70,173
+1,651
| +2% | +$407K | 0.01% | 925 |
|
|
2022
Q4 | $19.1M | Buy |
68,522
+72
| +0.1% | +$18.2K | 0.01% | 849 |
|
|
2022
Q3 | $14.3M | Sell |
68,450
-56,601
| -45% | -$12.7M | 0.01% | 937 |
|
|
2022
Q2 | $29.5M | Buy |
125,051
+40,025
| +47% | +$8.14M | 0.01% | 732 |
|
|
2022
Q1 | $15.3M | Sell |
85,026
-6,968
| -8% | -$1.33M | 0.01% | 1036 |
|
|
2021
Q4 | $19.9M | Buy |
91,994
+21,581
| +31% | +$4.24M | 0.01% | 955 |
|
|
2021
Q3 | $13M | Sell |
70,413
-1,012
| -1% | -$199K | 0.01% | 1111 |
|
|
2021
Q2 | $12.8M | Sell |
71,425
-1,092
| -2% | -$208K | 0.01% | 1116 |
|
|
2021
Q1 | $12.1M | Sell |
72,517
-15,542
| -18% | -$2.59M | 0.01% | 1110 |
|
|
2020
Q4 | $13.4M | Sell |
88,059
-341
| -0.4% | -$44.7K | 0.01% | 1001 |
|
|
2020
Q3 | $8.93M | Sell |
88,400
-5,913
| -6% | -$649K | ﹤0.01% | 1080 |
|
|
2020
Q2 | $11.4M | Buy |
94,313
+19,392
| +26% | +$2.18M | 0.01% | 942 |
|
|
2020
Q1 | $7.1M | Sell |
74,921
-398
| -0.5% | -$37.8K | 0.01% | 1039 |
|
|
2019
Q4 | $6.63M | Buy |
75,319
+2,370
| +3% | +$209K | ﹤0.01% | 1269 |
|
|
2019
Q3 | $5.82M | Sell |
72,949
-1,135
| -2% | -$91.4K | ﹤0.01% | 1296 |
|
|
2019
Q2 | $5.78M | Sell |
74,084
-13,804
| -16% | -$1.29M | ﹤0.01% | 1333 |
|
|
2019
Q1 | $10.3M | Sell |
87,888
-34,507
| -28% | -$4.02M | 0.01% | 1045 |
|
|
2018
Q4 | $13.3M | Buy |
122,395
+44,960
| +58% | +$5.21M | 0.01% | 880 |
|
|
2018
Q3 | $9.9M | Buy |
77,435
+27,729
| +56% | +$3.43M | 0.01% | 980 |
|
|
2018
Q2 | $5.62M | Buy |
49,706
+5,355
| +12% | +$589K | ﹤0.01% | 1187 |
|
|
2018
Q1 | $4.98M | Sell |
44,351
-1,380
| -3% | -$175K | ﹤0.01% | 1220 |
|
|
2017
Q4 | $6.77M | Sell |
45,731
-1,265
| -3% | -$161K | ﹤0.01% | 1078 |
|
|
2017
Q3 | $5.51M | Buy |
46,996
+16,229
| +53% | +$2.07M | ﹤0.01% | 1171 |
|
|
2017
Q2 | $3.99M | Buy |
30,767
+1,192
| +4% | +$149K | ﹤0.01% | 1338 |
|
|
2017
Q1 | $4M | Sell |
29,575
-2,402
| -8% | -$364K | ﹤0.01% | 1325 |
|
|
2016
Q4 | $4.59M | Sell |
31,977
-2,304
| -7% | -$294K | ﹤0.01% | 1244 |
|
|
2016
Q3 | $4.05M | Sell |
34,281
-3,094
| -8% | -$372K | ﹤0.01% | 1246 |
|
|
2016
Q2 | $3.96M | Sell |
37,375
-5,049
| -12% | -$563K | ﹤0.01% | 1181 |
|
|
2016
Q1 | $4.73M | Buy |
42,424
+2,354
| +6% | +$298K | ﹤0.01% | 1075 |
|
|
2015
Q4 | $6.28M | Buy |
40,070
+3,769
| +10% | +$549K | 0.01% | 990 |
|
|
2015
Q3 | $4.76M | Sell |
36,301
-858
| -2% | -$138K | ﹤0.01% | 1078 |
|
|
2015
Q2 | $6.46M | Buy |
37,159
+1,119
| +3% | +$201K | 0.01% | 1012 |
|
|
2015
Q1 | $6.21M | Sell |
36,040
-500
| -1% | -$76.2K | 0.01% | 1031 |
|
|
2014
Q4 | $4.73M | Buy |
36,540
+2,800
| +8% | +$361K | ﹤0.01% | 1151 |
|
|
2014
Q3 | $4.34M | Sell |
33,740
-970
| -3% | -$100K | ﹤0.01% | 1165 |
|
|
2014
Q2 | $3.07M | Sell |
34,710
-296
| -0.8% | -$28.5K | ﹤0.01% | 1459 |
|
|
2014
Q1 | $3.29M | Sell |
35,006
-1,761
| -5% | -$180K | ﹤0.01% | 1364 |
|
|
2013
Q4 | $4.16M | Buy |
36,767
+222
| +0.6% | +$20K | ﹤0.01% | 1210 |
|
|
2013
Q3 | $2.88M | Sell |
36,545
-6,467
| -15% | -$473K | ﹤0.01% | 1416 |
|
|
2013
Q2 | $2.83M | Buy |
+43,012
| New | +$2.77M | ﹤0.01% | 1372 |
|
Other funds holding UTHR
ACA
VPM
VCM
AllianceBernstein's UTHR Position: Q1 2026 in Review
AllianceBernstein increased its United Therapeutics (UTHR) stake by 6.8% in Q1 2026, buying an estimated $7.02M and bringing the position to 220,634 shares worth $108M. The position accounts for 0.03% of the portfolio, ranked #370.
AllianceBernstein first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. The position peaked at $250M in Q4 2024. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- AllianceBernstein held 220,634 shares of United Therapeutics worth $108M as of Q1 2026.
- AllianceBernstein bought 14,091 United Therapeutics shares in Q1 2026, an estimated $7.02M.
- United Therapeutics made up 0.03% of AllianceBernstein's portfolio in Q1 2026, its #370 holding.
- AllianceBernstein first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
- AllianceBernstein's United Therapeutics position peaked at $250M in Q4 2024.
- 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.